The Commissioner of Drugs and Substances Control adds the following substances to Schedule I:
(a) Synthetic cannabinoids: - (i) (S)-methyl 2-(1-(5-fluoropentyl)-1H-indazole-3- carboxamido)-3-methylbutanoate, commonly known as 5F-AMB;
- (ii) [N-[1-(aminocarbonyl)-2,2-dimethylpropyl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide, commonly known as ADB-FUBINACA;
- (iii) [Methyl 2-({1-[(4-fluorophenyl)methyl]-1Hindazole-3-carbonyl}amino)-3-methylbutanoate], commonly known as FUB-AMB.
(b) Synthetic opioid analgesics: - (i) trans-3,4-dichloro-N-[2-dimethylamino)cyclohexyl]-N-methyl-benzamide, commonly known as U-47700;
- (ii) para-fluorobutyryl fentanyl, commonly known as p-FBF;
- (iii) N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide, commonly known as acetyl fentanyl;
- (iv) 3,4-dichloro-N-[(1dimethylamino)cyclohexylmethyl]benzamide), commonly known as AH-7921.
(c) Analgesics: - (i) 4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]-2- piperidinylidene]-benzenesulfonamide, commonly known as W-18.
(d) Synthetic opioids: - (i) N-(1-phenethylpiperidin-4-yl)-Nphenylbutyramide, also known as N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide, (commonly known as butyryl fentanyl);
- (ii) N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-Nphenylpropionamide, also known as N-[1-[2-hydroxy-2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenylpropanamide, (commonly known as beta-hydroxythiofentanyl);
- (iii) N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide, (commonly known as furanyl fentanyl).